IGHE and ovarian cancer: The potential of activating the FcεR downstream pathway, and by inference anti-tumour IgE engagement of immune effector cells may have clinical significance, since higher intra-tumoural Lyn expression in gastric, lung and ovarian cancer is associated with more favourable prognosis.